The SMART trial raised questions about balloon-expandable valves in small aortic annuli; these new data offer some answers.

Abbott Laboratories, Inc. ABT recently announced the first patient procedures with its investigational transcatheter aortic ...

Costa believes that a potential global monetary reset, coupled with a weakening US dollar and rising inflation, could ...

Abbott has commenced the first subject procedures with its transcatheter aortic valve implantation (TAVI) system to treat ...

Abbott today announced the first patient procedures with its investigational transcatheter aortic valve implantation (TAVI) ...

Designed for patients needing a replacement valve, the company’s TAVI trial has found low rates of mortality after a year of ...

BusinessWire India Mumbai Maharashtra [India] November 25 SMT Sahajanand Medical Technologies a global leader in innovative ...

Abbott (NYSE: ABT) today announced the first patient procedures with its investigational transcatheter aortic valve implantation (TAVI) balloon-expandable system for treating symptomatic severe aortic ...

The Myval THV series, known for its innovative contributions to transcatheter aortic valve replacement (TAVR) procedures, ...

This landmark initiative places SKIMS at the forefront of advanced cardiac care in the region, offering patients a minimally ...

Tavi Gevinson is a very talented actor and writer. She was just fifteen years old when she founded the fashion magazine ...